Acadia Pharmaceuticals Inc.
USPTO PatentsView assignee record - 32 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Acadia ranks #9,688 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 9 technology areas.
- #9,688
- of 49,997 US assignees by volume
- 49th percentile
- by Innovation Score (34.7/100)
- 13.2
- avg claims per patent
- +46%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9688 · US Corporation #9,688 · 32 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 32 grants
- UPPER-Q #9,688/49,997
- PHOTO-FINISH 7AC
- CPC-NARROW A61P · 9 areas
- INNOV-THIN 34.7/100
- CLAIMS-RICH 13.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +46% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: 7AC Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Acadia’s 34.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Acadia
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Acadia Pharmaceuticals · this assignee
Acadia Pharmaceuticals · this assignee
35 score
- Afiniti Europe · near
Afiniti Europe · near
35 score
- Airgain · near
Airgain · near
35 score
- Ideastream Consumer… · near
Ideastream Consumer… · near
35 score
- Mojix · near
Mojix · near
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Acadia's Innovation Score is 34.7/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Acadia?
Each dot is one of Acadia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Acadia’s own 13.2 claims/patent is at or below the 16.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Acadia's grants concentrate
Acadia Pharmaceuticals Inc. is a focused PatentsView assignee: 9 CPC subclasses with 62.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2018. By volume, Acadia sits between 7AC Technologies, Inc. and American International Group, Inc..
Acadia's three-year grant acceleration
Acadia Pharmaceuticals Inc. shows 8 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Acadia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- 7AC
7AC Technologies, Inc.
32 patents
- 8×8
8×8, Inc.
32 patents
- 9224-5489 Quebec
9224-5489 Quebec Inc.
32 patents
- AB Sandvik Coroma…
AB Sandvik Coromant
32 patents
- ADA Carbon Soluti…
ADA Carbon Solutions, LLC
32 patents
- ADP Gauselmann
ADP Gauselmann GMBH
32 patents
- Altergon
Altergon SA
32 patents
- American Internat…
American International Group, Inc.
32 patents
- Acadia Pharmaceut… ◀
Acadia Pharmaceuticals Inc.
32 patents
What this shows Acadia holds 32 patents at rank #9,686, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Acadia
By rank, the assignees closest to #9,686 in granted patent volume.
- 7AC Technologies, Inc. #9,682 · 32 patents
- 8×8, Inc. #9,683 · 32 patents
- 9224-5489 Quebec Inc. #9,684 · 32 patents
- AB Sandvik Coromant #9,685 · 32 patents
- ADA Carbon Solutions, LLC #9,687 · 32 patents
- ADP Gauselmann GMBH #9,688 · 32 patents
- Altergon SA #9,689 · 32 patents
- American International Group, Inc. #9,690 · 32 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Acadia's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Acadia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Acadia ranks #980 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (35 here).
Acadia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 49th percentile higher than 49% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 9.4% |
| 2016 | 3 | 9.4% |
| 2017 | 4 | 12.5% |
| 2018 | 1 | 3.1% |
| 2019 | 2 | 6.3% |
| 2020 | 4 | 12.5% |
| 2021 | 7 | 21.9% |
| 2022 | 4 | 12.5% |
| 2023 | 3 | 9.4% |
| 2024 | 1 | 3.1% |
Which technologies does Acadia Pharmaceuticals Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Acadia Pharmaceuticals Inc.'s patent record in context - here's where to go next.
- Acadia Pharmaceuticals Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 62.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #9,688 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Acadia Pharmaceuticals Inc. against 7AC Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.